Package 55150-231-10

Brand: fondaparinux sodium

Generic: fondaparinux sodium
NDC Package

Package Facts

Identity

Package NDC 55150-231-10
Digits Only 5515023110
Product NDC 55150-231
Product ID 55150-231_a193830a-dc25-412a-b047-d2fa77d9dbbc
Description

10 SYRINGE, GLASS in 1 CARTON (55150-231-10) / .4 mL in 1 SYRINGE, GLASS (55150-231-00)

Marketing

Marketing Status
Marketed Since 2017-12-26
Brand fondaparinux sodium
Generic fondaparinux sodium
Sample Package No

Linked Drug Pages (1)

FONDAPARINUX SODIUM ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "a193830a-dc25-412a-b047-d2fa77d9dbbc", "openfda": {"unii": ["X0Q6N9USOZ"], "rxcui": ["861356", "861360", "861363", "861365"], "spl_set_id": ["8ea61d0d-4403-4d9f-a946-85a459cc0aa0"], "manufacturer_name": ["Eugia US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE, GLASS in 1 CARTON (55150-231-02)  / .4 mL in 1 SYRINGE, GLASS (55150-231-00)", "package_ndc": "55150-231-02", "marketing_start_date": "20171226"}, {"sample": false, "description": "10 SYRINGE, GLASS in 1 CARTON (55150-231-10)  / .4 mL in 1 SYRINGE, GLASS (55150-231-00)", "package_ndc": "55150-231-10", "marketing_start_date": "20171226"}], "brand_name": "FONDAPARINUX SODIUM", "product_id": "55150-231_a193830a-dc25-412a-b047-d2fa77d9dbbc", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Factor Xa Inhibitor [EPC]", "Factor Xa Inhibitors [MoA]"], "product_ndc": "55150-231", "generic_name": "FONDAPARINUX SODIUM", "labeler_name": "Eugia US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "FONDAPARINUX SODIUM", "active_ingredients": [{"name": "FONDAPARINUX SODIUM", "strength": "5 mg/.4mL"}], "application_number": "ANDA206918", "marketing_category": "ANDA", "marketing_start_date": "20171226", "listing_expiration_date": "20261231"}